KR880013576A - 골수억제 조성물 및 이의 용도 - Google Patents
골수억제 조성물 및 이의 용도 Download PDFInfo
- Publication number
- KR880013576A KR880013576A KR870011995A KR870011995A KR880013576A KR 880013576 A KR880013576 A KR 880013576A KR 870011995 A KR870011995 A KR 870011995A KR 870011995 A KR870011995 A KR 870011995A KR 880013576 A KR880013576 A KR 880013576A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- acceptable salt
- radionuclide
- ligand
- physiologically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Steroid Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (14)
- 에틸렌디아민테트라메틸렌포스폰산, 디에틸렌트리아민펜타메틸렌포스폰산, 하이드록시에틸에틸렌디아민 트리메틸렌포스폰산, 니트릴로트리메티렌포스폰산 또는 트리스(2-아미노에틸)아민헥사메틸렌포스폰산중 적어도 하나의 리간드, 또는 그의 생리학적으로 허용되는 염과 착화합된, 사마리움(Samarium)-153, 가돌리니움(Gadolinium)-159, 또는 홀미움(Holmium)-116중 적어도 하나의 방사성 핵종을 가진, 골수억제량의 적어도 하나의 골수억제 조성물을 골수억제 치료를 필요로 하는 포유동물에게 투여함을 포함하는 골수억제 방법.
- 제 1 항에 있어서, 방사성 핵종이 사마리움-153인 방법.
- 제 1 항에 있어서, 방사성 핵종이 홀미움-166인 방법.
- 제 1 항에 있어서, 방사성 핵종이 가돌리니움-159인 방법.
- 제 1 항 내지 4항중 어느 하나에 있어서, 리간드가 에틸렌디아민테트라메틸렌포스폰산 또는 그의 생리학적으로 허용되는 염인 방법.
- 제 1 항 또는 2항에 있어서, 리간드가 하이드록시에틸렌디아민트리메틸렌포스폰산 또는 그의 생리학적으로 허용되는 염인 방법.
- 제 1 항 또는 2항에 있어서, 리간드가 디에틸렌트리아민펜타메틸렌포스폰산 또는 그의 생리학적으로 허용되는 염인 방법.
- 제 1 항에 있어서, 백혈병, 림프종, 골수종 또는 호지킨병(Hodgkin's disease)을 치료하기 위한 하나 이상의 치료섭생법과 관련하여 사용되는 방법.
- 제 1 항에 있어서, 적어도 하나의 (a) 하나이상의 골수억제제, 및/또는 (b) 하나이상의 화학요법제, 및/또는 (c) 하나이상의 방사선 요법제 또는 방사선요법을 사용하는 추가의 치료섭생법과 관련하여 사용되는 방법.
- 제 1 항에 있어서, 전신 방사 또는 표적된 외부 방사와 관련하여 사용되는 방법.
- 제 1 항 또는 10항에 있어서, 적어도 하나의 화학요법제를 사용하는 치료와 관련하여 사용되는 방법.
- 제11항에 있어서, 화학요법제가 디메틸부설판, 사이클로포스파미드, 비스클로로에틸니트로소우레아, 사이토신, 아라비노사이드, 또는 6-티오구아닌의 방법.
- 제 1 항에 있어서, 골수억제를 충분히 수행한후, 추가의 골수이식 단계를 포함하는 방법.
- 골수억제제로서 사용하기 위해 에틸렌디아민 테트라메틸렌포스폰산, 디에틸렌트리아민펜타메틸렌포스폰산, 하이드록시에틸에틸렌디아민트리메틸렌포스폰산, 니트릴로트리메틸렌포스폰산 또는 트리스(2-아미노에틸)아민헥사메틸렌포스폰산중 적어도 하나의 리간드, 또는 그의 생리학적으로 허용되는 염과 사마리움-153, 가돌리니움=159, 또는 홀미움-166중 적어도 하나의 방사성 핵종을 가진 조성물.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5066787A | 1987-05-18 | 1987-05-18 | |
US050667 | 1987-05-18 | ||
US050,667 | 1987-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880013576A true KR880013576A (ko) | 1988-12-21 |
KR950009101B1 KR950009101B1 (ko) | 1995-08-14 |
Family
ID=21966649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870011995A KR950009101B1 (ko) | 1987-05-18 | 1987-10-29 | 골수 억제용 조성물 |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0291605B1 (ko) |
JP (1) | JP2536883B2 (ko) |
KR (1) | KR950009101B1 (ko) |
AT (1) | ATE87488T1 (ko) |
AU (1) | AU603389B2 (ko) |
CA (1) | CA1324953C (ko) |
DE (1) | DE3785195T2 (ko) |
DK (1) | DK173930B1 (ko) |
FI (1) | FI874785A0 (ko) |
IE (1) | IE61900B1 (ko) |
IL (1) | IL84308A (ko) |
NZ (1) | NZ222304A (ko) |
PH (1) | PH24887A (ko) |
PT (1) | PT86020B (ko) |
ZA (1) | ZA878169B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976950A (en) * | 1988-12-19 | 1990-12-11 | The Dow Chemical Company | Bone marrow suppressing agents |
MC2260A1 (fr) * | 1990-06-18 | 1993-04-26 | Dow Chemical Co | Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation |
US5308606A (en) * | 1991-01-30 | 1994-05-03 | The Dow Chemical Company | Method of treating and/or diagnosing soft tissue tumors |
CN1065769C (zh) * | 1997-07-03 | 2001-05-16 | 中国原子能科学研究院 | 一种放射性药物制剂的制备方法 |
US6776977B2 (en) | 2001-01-09 | 2004-08-17 | Bristol-Myers Squibb Pharma Company | Polypodal chelants for metallopharmaceuticals |
CN103012450B (zh) * | 2012-12-12 | 2015-04-22 | 南开大学 | 一种具有磁制冷和铁电双功能钆化合物及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL74902A (en) * | 1984-06-04 | 1990-12-23 | Dow Chemical Co | Organic amine phosphonic acid complexes with particle-emitting radionuclides for the treatment of calcific tumors |
DE3577550D1 (de) * | 1984-09-21 | 1990-06-13 | Dow Chemical Co | Aminocarbonsaeurekomplexe zur behandlung von knochentumoren. |
EP0225409A1 (en) * | 1985-12-02 | 1987-06-16 | The Dow Chemical Company | Organic amine phosphonic acid complexes for the treatment of calcific tumors |
-
1987
- 1987-10-27 NZ NZ222304A patent/NZ222304A/xx unknown
- 1987-10-28 IE IE289087A patent/IE61900B1/en not_active IP Right Cessation
- 1987-10-29 IL IL84308A patent/IL84308A/xx not_active IP Right Cessation
- 1987-10-29 AU AU80453/87A patent/AU603389B2/en not_active Expired
- 1987-10-29 PH PH36000A patent/PH24887A/en unknown
- 1987-10-29 CA CA000550546A patent/CA1324953C/en not_active Expired - Lifetime
- 1987-10-29 KR KR1019870011995A patent/KR950009101B1/ko not_active IP Right Cessation
- 1987-10-29 PT PT86020A patent/PT86020B/pt not_active IP Right Cessation
- 1987-10-30 JP JP62273610A patent/JP2536883B2/ja not_active Expired - Lifetime
- 1987-10-30 AT AT87309644T patent/ATE87488T1/de not_active IP Right Cessation
- 1987-10-30 EP EP87309644A patent/EP0291605B1/en not_active Expired - Lifetime
- 1987-10-30 DE DE8787309644T patent/DE3785195T2/de not_active Expired - Lifetime
- 1987-10-30 FI FI874785A patent/FI874785A0/fi not_active Application Discontinuation
- 1987-10-30 DK DK198705706A patent/DK173930B1/da not_active IP Right Cessation
- 1987-10-30 ZA ZA878169A patent/ZA878169B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0291605A2 (en) | 1988-11-23 |
ZA878169B (en) | 1989-07-26 |
AU603389B2 (en) | 1990-11-15 |
DK173930B1 (da) | 2002-02-25 |
AU8045387A (en) | 1988-11-24 |
FI874785A0 (fi) | 1987-10-30 |
JPS63287729A (ja) | 1988-11-24 |
EP0291605B1 (en) | 1993-03-31 |
DK570687A (da) | 1988-11-19 |
JP2536883B2 (ja) | 1996-09-25 |
PT86020B (pt) | 1992-07-31 |
CA1324953C (en) | 1993-12-07 |
NZ222304A (en) | 1990-10-26 |
IE61900B1 (en) | 1994-11-30 |
DE3785195T2 (de) | 1993-07-15 |
DK570687D0 (da) | 1987-10-30 |
IE872890L (en) | 1988-11-18 |
KR950009101B1 (ko) | 1995-08-14 |
PT86020A (en) | 1989-05-31 |
EP0291605A3 (en) | 1989-07-26 |
ATE87488T1 (de) | 1993-04-15 |
PH24887A (en) | 1990-12-26 |
IL84308A (en) | 1992-09-06 |
DE3785195D1 (de) | 1993-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1073460A1 (en) | Substituted 1, 3-oxathiolanes with antiviral properties | |
HK152395A (en) | Bone marrow suppressing agents | |
HUT57994A (en) | Radiopharmacological compositions and process for producing and administering them | |
KR880013576A (ko) | 골수억제 조성물 및 이의 용도 | |
IL82574A0 (en) | Fused imidazoheterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
GR3031540T3 (en) | Anti-arrhythmic and cardioprotective substituted indenoylguanidines | |
EP0201005A3 (en) | 99mtc(iii)myocardial imaging agents which are non-reducable in vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20080808 Year of fee payment: 14 |
|
LAPS | Lapse due to unpaid annual fee |